Long-term outcome of patients treated with hematopoietic growth factors for idiosyncratic drug-induced agranulocytosis.

Authors	Emmanuel Andrès, Esther Noel, Frédéric Maloisel
Journal	The American journal of medicine (Am J Med) Vol. 116 Issue 5 Pg. 354 (Mar 01 2004) ISSN: 0002-9343 [Print] United States
PMID	14984824 (Publication Type: Letter)
Chemical References	Granulocyte Colony-Stimulating Factor Granulocyte-Macrophage Colony-Stimulating Factor
Topics	Adult Aged Aged, 80 and over Agranulocytosis (chemically induced, drug therapy) Female Follow-Up Studies Granulocyte Colony-Stimulating Factor (adverse effects, therapeutic use) Granulocyte-Macrophage Colony-Stimulating Factor (adverse effects, therapeutic use) Humans Male Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!